Free Trial

Clorox (CLX) to Release Quarterly Earnings on Monday

Clorox logo with Consumer Staples background

Clorox (NYSE:CLX - Get Free Report) is projected to post its quarterly earnings results after the market closes on Monday, February 3rd. Analysts expect Clorox to post earnings of $1.39 per share and revenue of $1,626,355.48 billion for the quarter. Clorox has set its FY25 guidance at $6.65-$6.90 EPS and its FY 2025 guidance at 6.650-6.900 EPS.Investors that wish to register for the company's conference call can do so using this link.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The firm had revenue of $1.76 billion for the quarter, compared to analysts' expectations of $1.64 billion. During the same quarter in the previous year, the company posted $0.49 EPS. The company's revenue was up 27.0% compared to the same quarter last year. On average, analysts expect Clorox to post $7 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Clorox Trading Up 1.9 %

CLX stock traded up $3.08 during trading on Monday, reaching $162.35. 1,244,232 shares of the stock were exchanged, compared to its average volume of 1,008,424. The business has a 50 day moving average price of $163.66 and a 200-day moving average price of $157.66. Clorox has a 1 year low of $127.60 and a 1 year high of $171.37. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The firm has a market capitalization of $20.10 billion, a price-to-earnings ratio of 56.57, a P/E/G ratio of 2.92 and a beta of 0.42.

Clorox Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be issued a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 3.01%. The ex-dividend date is Wednesday, January 29th. Clorox's dividend payout ratio is presently 170.04%.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on CLX shares. DA Davidson lifted their target price on Clorox from $153.00 to $171.00 and gave the company a "neutral" rating in a research report on Monday, November 4th. Evercore ISI dropped their price target on shares of Clorox from $140.00 to $139.00 and set an "underperform" rating for the company in a research report on Monday, October 14th. StockNews.com lowered Clorox from a "buy" rating to a "hold" rating in a research report on Sunday, January 5th. Jefferies Financial Group upgraded Clorox from a "hold" rating to a "buy" rating and raised their price target for the stock from $174.00 to $187.00 in a research report on Tuesday, October 1st. Finally, TD Cowen upgraded Clorox from a "sell" rating to a "hold" rating and boosted their price objective for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. Four analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has issued a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $156.54.

Check Out Our Latest Report on CLX

Clorox Company Profile

(Get Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Further Reading

Earnings History for Clorox (NYSE:CLX)

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

How To Invest in Crypto as A Complete BEGINNER in 2025
3 AI Bargain Stocks to BUY NOW After the DeepSeek Crash
NVIDIA Stock Under Pressure: DeepSeek and the AI Tech War

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines